IP Library Granted Patent US 8,043,252
Granted Patent B2
US 8,043,252 · App. 12/004,514 · Granted Oct 25, 2011

Nitric oxide decontamination of the upper respiratory tract

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,043,252
App. No.
12/004,514
Granted
Oct 25, 2011
Kind
B2
Abstract

A method of topically treating the respiratory tract of a mammal with nitric oxide exposure includes the steps of providing a source of nitric oxide containing gas and delivering the nitric oxide containing gas nasally to the upper respiratory tract of the mammal. Also provided are several designs for a nasal delivery device for the controlled nasal deliver the nitric oxide containing gas.

Claims (36)

1. A nasal delivery device for delivering nitric oxide containing gas to an upper respiratory tract of a mammal, said device comprising:

a source of nitric oxide containing gas;

a nasal interface adapted to provide fluid communication between the source of nitric oxide containing gas and a first nostril of the mammal;

a flow-control valve for controlling the flow of the nitric oxide containing gas from the source to the mammal;

a one-way valve operable to be inserted into a second nostril of the mammal; and

a mouthpiece comprising a resistive element operable to close the soft palate of the mammal.

2. The nasal delivery device of claim 1 , wherein the nasal interface comprises a nosepiece operable to be inserted into the first a nostril of a mammal.

3. The nasal delivery device of claim 1 , further comprising a pressure monitor operable to detect a pressure within an oral cavity of the mammal.

4. The nasal delivery device of claim 3 , further comprising a controller with logic such that the flow control valve is opened when a threshold pressure is detected in the oral cavity of the mammal.

5. The nasal delivery device of claim 3 , wherein the pressure monitor is operably connected to the mouthpiece.

6. The nasal delivery device of claim 1 , further comprising a gas blender.

7. The nasal delivery device of claim 1 , wherein the supply unit further comprises an NO analyzer.

8. The nasal delivery device of claim 1 , wherein the supply unit is operable to deliver about 1 liter per minute of the nitric oxide containing gas.

9. The nasal delivery device of claim 1 , wherein the one-way valve is operable to restrict inward flow upon delivery of the nitric oxide containing gas.

10. The nasal delivery device of claim 1 , wherein the one-way valve is operable to allow the nitric oxide containing gas to exit the upper respiratory tract.

11. The nasal delivery device of claim 1 , wherein the resistive element operable to provide at least about 5 cm H 2 O pressure in an oral cavity of the mammal.

12. The nasal delivery device of claim 1 , further comprises a collapsible reservoir.

13. The nasal delivery device of claim 12 , wherein collapsible reservoir has a volume that is substantially equal to the volume of the upper respiratory tract of the mammal.

14. The nasal delivery device of claim 13 , wherein the volume of the collapsible reservoir is about 20 mL to about 50 mL.

15. A nasal delivery device for delivering a nitric oxide containing gas to an upper respiratory tract of a mammal, said device comprising:

a collapsible reservoir comprising nitric oxide containing gas and having a volume substantially equal to the volume of the upper respiratory tract of the mammal;

a nasal interface adapted to provide fluid communication between a nose of the mammal and the collapsible reservoir; and

a control valve for controlling the delivery of the nitric oxide containing gas from the collapsible reservoir to the nasal interface.

16. The nasal delivery device of claim 15 , wherein the volume of the collapsible reservoir ranges from about 20 mL to about 50 mL.

17. The nasal delivery device of claim 16 , further comprising a fill port for filling the collapsible reservoir with nitric oxide containing gas from a source of nitric oxide gas.

18. The nasal delivery device of claim 15 , wherein the nasal interface is a nasal mask operable to be placed around the nose of the mammal.

19. The nasal delivery device of claim 15 , wherein the nasal interface is a nosepiece operable to be inserted into at least one nostril of a mammal.

20. The nasal delivery device of claim 19 , wherein the nosepiece comprises an insert operable to seal the nostril of the mammal.

21. A nasal delivery device for delivering a nitric oxide containing gas to an upper respiratory tract of a mammal, the device comprising:

a source of breathable gas connected via tubing to a nasal interface for providing a gas stream of breathable gas to the mammal nasally;

an inspiration flow profile sensor that measures the inspiration flow profile of the inspiration breath of the mammal;

a source of nitric oxide containing gas operably in fluid communication with the gas stream of the breathable gas;

a flow controller located between the a source of nitric oxide containing gas and the gas stream for releasing nitric oxide containing gas to the nasal interface;

a controller for triggering the release of nitric oxide containing gas to the nasal interface at a predetermined time close to the end of the mammal's inspiration and at a flow rate that confines the nitric oxide containing gas in the upper respiratory tract of the mammal.

22. The nasal delivery device of claim 21 , wherein the predetermined time is a time after the inspiratory flow rate reaches maximum and returns to close to a zero inspiratory flow rate.

23. The nasal delivery device of claim 21 , wherein the nasal interface is a nosepiece operable to be inserted into at least one nostril of the mammal.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2025
From: SENSORMEDICS CORPORATION
To: ZOLL MEDICAL CORPORATION
Reel/Frame 072869/0633 →
CHANGE OF NAME Recorded Aug 12, 2022
From: ADVANCED INHALATION THERAPIES (AIT) LTD.
To: BEYOND AIR LTD
Reel/Frame 061164/0767 →
SECURITY INTEREST Recorded May 9, 2019
From: SENSORMEDICS CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 049126/0905 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2018
From: AIT THERAPEUTICS, INC.
To: ADVANCED INHALATION THERAPIES (AIT) LTD.
Reel/Frame 047562/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2018
From: ADVANCED INHALATION THERAPIES (AIT) LTD.
To: AIT THERAPEUTICS, INC.
Reel/Frame 046234/0061 →
SECOND LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: SENSORMEDICS CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 045782/0851 →
FIRST LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: SENSORMEDICS CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 045968/0865 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2017
From: PULMONOX TECHNOLOGIES CORPORATION
To: ADVANCED INHALATION THERAPIES (AIT) LTD.
Reel/Frame 043779/0488 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2008
From: MILLER, CHRISTOPHER C.
To: PULMONOX TECHNOLOGIES CORPORATION
Reel/Frame 020538/0986 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2008
From: STENZLER, ALEX
To: SENSORMEDICS CORPORATION
Reel/Frame 020538/0106 →